CEVAXIN

Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) When Co-administered With a Seasonal Quadrivalent Influenza Vaccine in Older Adults: Results of a Phase 3, Open-Label, Randomized Controlled Trial

Reynaldo Chandler, Nathali Montenegro, Cecilia Llorach et al. · Clinical Infectious Diseases · 2024 · 36 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study

Timo Vesikari, Xavier Sáez‐Llorens, Vesna Blazevic et al. · Vaccine · 2022 · 26 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17

Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials

Rahnuma Wahid, Laina D. Mercer, Tirza De León et al. · The Lancet Microbe · 2022 · 20 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17

Confronting the challenge: a regional perspective by the Latin American pediatric infectious diseases society (SLIPE) expert group on respiratory syncytial virus—tackling the burden of disease and implementing preventive solutions

Roberto Debbag, María L. Ávila-Agüero, José António Fraiz Brea et al. · Frontiers in Pediatrics · 2024 · 10 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17